SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Reports that AMD notified customers of a roughly 10% chip price increase beginning in Q4, linked to higher TSMC wafer costs, are fueling a rally to all-time highs that has traders eyeing trillion-dollar market cap status. Bulls frame the hike as evidence of pricing power, while skeptics call the move an overextended, hype-driven short squeeze at stretched valuations.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is surging after the U.S. announced a security agreement with Denmark and Greenland granting Washington permanent military access to the island, where the company's Tanbreez rare earth project is located, with traders also framing the move ahead of an upcoming U.S.-China summit set to address critical minerals. The community is heavily bullish, with many anticipating a short squeeze on elevated short interest, while skeptics counter that the pact covers security rather than mining rights and does little for a project still years from production.

Maase, Inc. operates as a integrated provider and operator of artificial intelligence (AI) centric full-scene digital systems. The firm focus on areas of flexible energy deployment and intelligent commercial network operation, and provide closed-loop solutions from computing infrastructure, smart hardware and full-scene services, aiming to achieve large-scale implementation of AI technologies across industries. The company was founded by Hai Feng Yu on August 6, 2018 and is headquartered in Qingdao, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is drawing attention after a run of back-to-back enterprise AI contract announcementscompute-capacity leases and prepaid token/API service agreements, including a large 12-month compute deal with VirtAI Techwhich traders view as a shift from one-off projects toward recurring revenue. The community is split between bulls citing the accelerating contract cadence and an unusually heavy volume spike as confirmation, and skeptics arguing the signed contracts still need to convert into recognized revenue, margin, and cash.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Shares are sliding after Novo Nordisk's Capital Markets Day, where long-term pipeline and growth targets failed to ease investor concerns about Eli Lilly's competitive lead and looming semaglutide patent expirations. The community is split, with many traders criticizing management's presentation and calling for leadership change, while dip-buyers see an oversold stock at a cheap valuation and some claim the drop is a coordinated selloff despite positive CagriSema head-to-head data against Lilly's tirzepatide.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

A sharp, short-squeeze-fueled rally is dominating the conversation, with traders citing reported but unconfirmed talks for SK Hynix to produce memory chips at Intel's Ohio site and CEO Lip-Bu Tan's comments that Intel can meet only about half of customer CPU demand as AI shifts toward inference and agentic workloads. Bulls see heavy call-option buying, dark-pool activity, and ongoing deal speculation keeping the run alive, while skeptics call the move momentum-driven with no partnership confirmed.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is trending as its shares slide to 52-week lows, a steep drawdown traders tie to valuation compression on a still-elevated multiple, the failed Salad and Go bid that rival 7Brew topped, and dilution concerns around a shelf registration. The community is sharply divided between dip-buyers calling the stock oversold on strong store growth, revenue beats, and raised guidance, and bears who argue it remains too expensive as consumer and restaurant peers broadly weaken.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Bitcoin's rebound is lifting crypto-treasury stocks, putting Strive in focus as it climbs alongside peers like Strategy while notably underperforming them. Traders are split on the laggard action  some suspect warrant exercises are creating dilution, others blame market-maker suppression and heavy short positioning, while bulls point to Strive's accelerating Bitcoin accumulation and squeeze potential.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm is rallying with the broader chip sector as traders rotate back into semis on booming CPU demand for agentic AI, with some crediting Meta's Muse announcement as a fresh read-through for AI-CPU suppliers and the stock building on CEO Rene Haas's comments that supply constraints have eased and Arm can convert multi-billion-dollar AGI CPU demand into revenue. Community sentiment is largely bullish amid heavy call buying, though skeptics counter that there is no fresh company-specific news and the move is simply the sector bid.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoin's rally to multi-month highs is driving a sharp move in Strategy and other crypto-linked stocks, reinforced by the company's regulatory filing disclosing a 950 BTC purchase and STRC preferred-stock repurchases funded with cash rather than new share issuance through its ATM. Bullish traders are celebrating the move and speculating about a short squeeze, while skeptics argue the stock now trades at a substantial premium to its Bitcoin holdings per share and warn that dilution is coming.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Traders are reacting to the Federal Reserve's first rate hike in three years, with bulls arguing SoFi had already factored multiple hikes into its guidance and bears warning that higher rates will pressure its lending business and keep the stock suppressed. Sentiment is also colored by the stock's persistent underperformance versus Robinhood and other fintech peers, along with recurring complaints about a repetitive intraday pattern, perceived manipulation, and management's dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novartis is drawing attention after its Phase 3 HARBOR study of del-desiran in myotonic dystrophy type 1 missed its primary endpoint, following the earlier pelacarsen cardiovascular-trial failure. Traders are debating the damage to Novartis pipeline and acquisition strategy, with some calling for board or management changes while others view the selloff as an overreaction.

Novartis Halts Experimental ALS Drug Trial but Acquires Brain Delivery Platform

Novartis halted its mid-stage ALS drug trial for VHB937 but exercised a $125 million option to acquire Sironax's brain delivery platform.read more...

The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux 

Prostate cancer awareness spotlights Pfizer's Xtandi, Novartis' Pluvicto and clinical-stage programs from Candel and Janux.

LEGN’s New CEO From Novartis Paves Way For Buyout Speculation 

Equity

Legend’s new CEO Ingrid Zhang most recently served as chief commercial officer for Novartis International.


4 Prostate Cancer Drug Stocks to Watch During Awareness Month

Pfizer, Novartis, Janux Therapeutics and Candel Therapeutics offer varied prostate-cancer exposure, with established drugs and clinical or regulatory catalysts.

INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?

Incyte's strong product demand and pipeline progress fuel its 23% YTD rally, but valuation and near-term earnings pressure temper the outlook.

AZN's Etcamah Fails Late-Stage Study for First-line Breast Cancer

AstraZeneca's Etcamah fails to improve PFS significantly in a phase III first-line breast cancer study, while its approved use remains unaffected.

Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.

Key PointsNovartis recently announced bad news for its Lp(a)-lowering drug, pelacarsen...

Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s

LLY's immunology portfolio is gaining ground, with steady revenue growth, pipeline expansion and acquisitions broadening its next wave.

4 Small-Cap Stocks with Catalysts Investors Can’t Ignore

The biopharma trade has entered a fascinating stretch. Investors continue to focus heavily on the industry's giants, including Novartis (NYSE:NVS), Eli Lilly (NYSE:LLY), and Amgen (NASDAQ:AMGN), but the latest market action is a reminder that some of the biggest percentage moves in biotechnology can come from much smaller companies.

That is where the bull case for looking beyond the mega-caps begins. 24/7 Market News has urged investors to broaden the lens to smaller companies including Tenon Medical (NASDAQ:TNON), NeOnc Technologies Holdings (NASDAQ:NTHI), Opus Genetics (NASDAQ:IRD), and bioAffinity Technologies (NASDAQ:BIAF). These companies share one potentially important characteristic: their valuations can be heavily influenced by discrete clinical, regulatory, commercial, or financing milestones.

NVS Stock On Track For Worst Week In Over 7 Years After Two Trial Failures In A Week — Investor Reportedly Seeks Board Overhaul 

David Samra, managing director at Artisan Partners, told Reuters that Chairman Giovanni Caforio should tighten oversight of acquisitions, add an acquisitions committee, and recruit stronger board talent.


Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$141.83
Prev Close	$140.37
Open	$141.96
Dividend Yield	2.23%
50-Day Moving Average	$152.45
Beta	0.27
Avg. Volume	1.39M
PE Ratio	21.05

52-Week High	$170.46
52-Week Low	$121.57
Market Capitalization	$256.95B
EPS (Annual)	$7.25
Price to Book	6.19
Revenue Per Employee	$728,224.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVS Fundamentals